Please provide your email address to receive an email when new articles are posted on . The duration of antibiotic treatment for diabetic foot osteomyelitis can safely and effectively be reduced from ...
BiomX reports positive Phase 2 results for BX211 in diabetic foot osteomyelitis and prepares for upcoming Phase 2b trial of BX004. BiomX Inc. announced encouraging topline results from its Phase 2 ...
GAITHERSBURG, Md--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company advancing the world’s largest therapeutic phage initiative for treatment of ...
Adjuvant use of antibiotic-loaded bio-composite bone void filler (CERAMENT) locally was associated with increased infection clearance of diabetic foot osteomyelitis (DFO) compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results